Bocciarelli C, Caumont C, Samaison L, Cariou M, et al. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories. Hum Pathol 2021;114:99-109.
PMID: 34019865